Climb Bio, Inc.

CLYM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$13-$9-$21-$8
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$1$2$2
Change in WC-$3-$3$4$2
Other Non-Cash-$0-$0-$1-$0
Operating Cash Flow-$12-$11-$15-$6
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$24-$21-$59-$60
Inv. Sales/Matur.$39$25$16$7
Other Inv. Act.$0-$0$0$0
Investing Cash Flow$15$5-$43-$53
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0-$0-$0
Net Chg. in Cash$3-$6-$58-$59
Supplemental Information
Beg. Cash$23$29$87$146
End Cash$26$23$29$87
Free Cash Flow-$12-$11-$15-$6
Climb Bio, Inc. (CLYM) Financial Statements & Key Stats | AlphaPilot